Correlation Between Silicon Motion and CRISPR Therapeutics

Can any of the company-specific risk be diversified away by investing in both Silicon Motion and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silicon Motion and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silicon Motion Technology and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Silicon Motion and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silicon Motion with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silicon Motion and CRISPR Therapeutics.

Diversification Opportunities for Silicon Motion and CRISPR Therapeutics

0.29

Correlation Coefficient

Silicon Motion  CRISPR Therapeutics

Modest diversification

The 3 months correlation between Silicon and CRISPR is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Silicon Motion Technology and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Silicon Motion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silicon Motion Technology are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Silicon Motion i.e., Silicon Motion and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between Silicon Motion and CRISPR Therapeutics

Assuming the 90 days trading horizon Silicon Motion Technology is expected to generate 0.56 times more return on investment than CRISPR Therapeutics. However, Silicon Motion Technology is 1.77 times less risky than CRISPR Therapeutics. It trades about 0.36 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about 0.14 per unit of risk. If you would invest  3,585  in Silicon Motion Technology on April 23, 2025 and sell it today you would earn a total of  2,765  from holding Silicon Motion Technology or generate 77.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Silicon Motion Technology  vs.  CRISPR Therapeutics AG

Silicon Motion Technology

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Silicon Motion Technology are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Silicon Motion unveiled solid returns over the last few months and may actually be approaching a breakup point.

CRISPR Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Silicon Motion and CRISPR Therapeutics

The main advantage of trading using opposite Silicon Motion and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silicon Motion position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.

The idea behind Silicon Motion Technology and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.